710349-08-9

Upstream product

• 645-00-1 m-iodonitrobenzene 
• 10602-08-1 2-ethynylbenzyl alcohol 
• 3034-94-4 3-nitrophenylacetylene 
• 5159-41-1 2-iodobenzyl alcohol 

Downstream Products

• 710349-09-0 C₂₁H₁₃BrFNO₃ 
• 1202529-02-9 (E)-1-isopropyl-5-[1-(3-nitrophenyl)ethylidene]-5,10-dihydro-1H-indazolo[6,5-b]benzo[e]oxepin 
• 1202529-03-0 (E)-5-[1-(3-aminophenyl)ethylidene]-1-isopropyl-5,10-dihydro-1H-indazolo[6,5-b]benzo[e]oxepin 
• 1202529-04-1 (E)-1-isopropyl-5-[1-(3-nitrophenyl)-2-propenylidene]-5,10-dihydro-1H-indazolo[6,5-b]benzo[e]oxepin 
• 1202528-45-7 5-iodo-1-isopropyl-6-{2-[(3-nitrophenyl)ethynyl]-phenylmethyloxy}-1H-indazole 
• 1202527-15-8 (E)-1-isopropyl-5-{1-[3-(methanesulfonamide)phenyl] propylidene}-5,10-dihydro-1H-indazolo[6,5-b]benzo[e]oxepin 

Relevant academic research and scientific papers

TETRACYCLIC COMPOUND

Provided are a tetracyclic compound represented by the formula (I): [in the formula(I),the formula (A) represents a benzene ring or the like, X represents CH or a nitrogen atom, Q represents -O- or the like, R1, R2, and R3 may be the same or different and each represent a hydrogen atom or the like, 1, m, and n each represent an integer from one to the maximum substitutable number of substituents, and R4 and R5 may be the same or different and each represent a hydrogen atom or the like], or a pharmaceutically acceptable salt thereof, and the like.

TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS

The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula (I): or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula (I), including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula (I).